carnosine.tv
Home › Research › Boldyrev 2013

Physiology and pathophysiology of carnosine

Boldyrev AA, Aldini G, Derave W. Physiological Reviews, 2013; 93(4):1803-1845.

ReviewHumansOther animals

Design
Review
Subjects
not stated in abstract
Dose used in the study
not stated in abstract
Duration
not stated in abstract
What was measured
Narrative review of about a century of carnosine research: biochemical properties, tissue distribution, carnosinase, and preclinical and clinical findings.

What the authors reported

The authors describe carnosine as a dipeptide found in skeletal muscle and other excitable tissues, with methylated relatives (anserine, ophidine/balenine) in most animals other than humans. They attribute its physiological roles to pH buffering, metal-ion chelation, antioxidant activity and protection against advanced glycation and lipoxidation end-products. They report that preclinical and clinical studies in diabetes and its complications, eye disease, ageing and neurological disorders have shown promising results. They conclude that the L-histidine imidazole ring appears to be the main active component, while beta-alanine mainly governs carnosine synthesis, and they call for much more experimental work.

Limits of this study

Narrative review; the authors state that far more experimental work is needed to understand the molecule's functions and uses.

Source

PubMed 24137022 · doi:10.1152/physrev.00039.2012

Entry checked against abstract (University of Milan repository record, AIR) on 2026-10-11. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.